Fucose in fucosylated glycans is primarily assembled at multiple sets of N-acetyllactosamine (LN) and lacto-N-biose (LNB) units, which are known as Lewis antigens. The synthesis of these compounds is difficult due to the diversity of Lewis antigens on complex glycans. A promising strategy is to perform enzymatic fucosylation with oligosaccharide backbones because the method is stereoselective and synthetically efficient. However, purification is difficult with this method because heterogeneous glycans are produced. Herein, we developed a general strategy to perform sitespecific fucosylation on poly LN or LN/LNB hybrid backbones. We found that trifluoroacetyl glucosamine (GlcNTFA) can function as a GlcNAc substituent and be incorporated into the LN/LNB chain. The TFA group was readily converted to a butyloxycarbonyl (Boc) group, and the resulting GlcNBoc can be accepted by bacterial galactosyltransferases and provides steric hindrance to prevent fucosyltransferase recognition. Thus, enzymatic fucosylation can only occur specifically at GlcNAc sites within GlcNHBoc-containing poly LN/LNB. We demonstrated the feasibility of this strategy by efficiently synthesizing myeloglycans (dodecasaccharides) and internal/terminal fucosylated human milk oligosaccharides. This approach offers a solution to bypass complex chemical glycosylations and control the selectivity of enzymatic fucosylations. Thus, the method shows significant potential for the future synthesis of branched glycans, such as N-glycans and O-glycans.